This is a Validated Antibody Database (VAD) review about dog JAK1, based on 15 published articles (read how Labome selects the articles), using JAK1 antibody in all methods. It is aimed to help Labome visitors find the most suited JAK1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
JAK1 synonym: tyrosine-protein kinase JAK1; Janus kinase 1 (a protein tyrosine kinase); protein tyrosine kinase
Santa Cruz Biotechnology
mouse monoclonal (73) |
| Santa Cruz Biotechnology JAK1 antibody (Santa Cruz Biotechnology, sc- 136225) was used in western blot on human samples . Viral Immunol (2014) ncbi |
Abcam
rabbit polyclonal |
| In order to investigate the role of ANGII in the regulation of latent and active MMP-2 in rat heart, Abcam JAK1 antibody (Abcam, ab125051) was used in western blot on rat samples . Basic Res Cardiol (2014) ncbi |
Cell Signaling Technology
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell Signaling, 6G4) was used in western blot on human samples at 1:1000 (fig 4a). Br J Cancer (2019) ncbi |
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell Signaling, 3344) was used in western blot on mouse samples at 1:500 (fig 4e). Nat Commun (2018) ncbi |
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell signaling, 3344) was used in western blot on human samples (fig 3e). Nat Commun (2017) ncbi |
rabbit monoclonal (6G4) |
| In order to study mouse models of dilated cardiomyopathy to study calcium signaling, Cell Signaling Technology JAK1 antibody (Cell Signaling, 3344) was used in immunoprecipitation on mouse samples (fig 4) and in western blot on mouse samples (fig 4). PLoS ONE (2016) ncbi |
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell Signaling Technology, 3344) was used in western blot on mouse samples at 1:2000 (fig 9a). Drug Des Devel Ther (2016) ncbi |
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell Signaling Technology, 6G4) was used in western blot on mouse samples (fig 6c). J Exp Med (2016) ncbi |
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell Signaling Technology, 6G4) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi |
rabbit monoclonal (6G4) |
| Cell Signaling Technology JAK1 antibody (Cell Signaling Technology, 3344) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi |
rabbit monoclonal (6G4) |
| In order to analyze multidrug resistant human cancer cells and autocrime cytokine/JAK/STAT-signaling induces kynurenin synthesis, Cell Signaling Technology JAK1 antibody (Cell Signaling Technology, 3344) was used in western blot on human samples at 1:1000 (fig 4). PLoS ONE (2015) ncbi |
rabbit monoclonal (6G4) |
| In order to show that uPAR regulates nasopharyngeal carcinoma NPC progression, Cell Signaling Technology JAK1 antibody (Cell Signaling Technology, 3344) was used in western blot on human samples . Cell Cycle (2014) ncbi |
BD Biosciences
mouse monoclonal (73/JAK1) |
| BD Biosciences JAK1 antibody (BD Biosciences, 610231) was used in western blot on human samples at 1:1000 (fig 3a). Nat Commun (2016) ncbi |
mouse monoclonal (73/JAK1) |
| BD Biosciences JAK1 antibody (BD Biosciences, 610231) was used in western blot on mouse samples (fig 3a) and in western blot on human samples (fig 3f). J Clin Invest (2016) ncbi |
mouse monoclonal (73/JAK1) |
| In order to evaluate the effect of JAK1/2 inhibitor AZD1480 on IL-6-induced experimental prostate cancer metastases formation, BD Biosciences JAK1 antibody (BD Biosciences, 610231) was used in western blot on human samples at 0.25 ug/mL. Mol Cancer Ther (2014) ncbi |
Articles Reviewed
- He Y, Yan Y, Zhang H, Lin Y, Chen Y, Yan Y, et al. Methyl salicylate 2-O-?-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction. Drug Des Devel Ther. 2016;10:3183-3196 pubmed
- Textor A, Schmidt K, Kloetzel P, Weißbrich B, Perez C, Charo J, et al. Preventing tumor escape by targeting a post-proteasomal trimming independent epitope. J Exp Med. 2016;213:2333-2348 pubmed
- Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, et al. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline. Oncotarget. 2015;6:14796-813 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments